Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Future Microbiol ; 13: 1363-1373, 2018 09.
Article in English | MEDLINE | ID: mdl-30238769

ABSTRACT

AIM: To evaluate the effectiveness and safety of ertapenem in patients hospitalized at home. PATIENTS & METHODS: Retrospective analysis of data from Spanish Outpatient Parenteral Antimicrobial Therapy (OPAT) registry. RESULTS: Data from 1428 patients (median age 70 years; 5.4% institutionalized) and 1547 infectious processes (24% self-administration) were analyzed. Clinical cure or improvement was achieved in 93.8% of cases. Rate of related readmissions was 4.2%, of clinically important complications -3.9%, and of adverse drug reactions -3.2%. High comorbidity burden, contagion in nursing home and certain types of infection were associated with worse prognosis. Self-administration was effective and safe, except in case of nursing home-acquired infections. CONCLUSION: Ertapenem OPAT was effective and safe. Caregivers in nursing homes should be better trained in OPAT-related procedures.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacterial Infections/drug therapy , Ertapenem/administration & dosage , Home Care Services, Hospital-Based/statistics & numerical data , Aged , Aged, 80 and over , Anti-Bacterial Agents/adverse effects , Cohort Studies , Ertapenem/adverse effects , Female , Hispanic or Latino/statistics & numerical data , Humans , Male , Middle Aged , Nursing Homes/statistics & numerical data , Outpatients/statistics & numerical data , Registries , Retrospective Studies , Self Administration/statistics & numerical data
2.
Surg Endosc ; 32(9): 3936-3942, 2018 09.
Article in English | MEDLINE | ID: mdl-29492709

ABSTRACT

BACKGROUND: Endoscopic sleeve gastroplasty is a safe and feasible treatment for obesity. This study is focused on our technique modification which suggests a different suturing pattern in order to distribute suture tension more evenly. METHODS: A retrospective study of 148 patients (121 women) who underwent this procedure and were monitored for 12 months was conducted. The average age was 41.53 ± 10 years. The average BMI was 35.11 ± 5.5 kg/m2 with the average initial weight being 98.7 ± 17 kg. A subgroup of the first 72 patients (60 women) were monitored for 18 months. A new running "Z" stitch pattern was used to provide gastric cavity reduction by means of 4 parallel suture rows. The stitch pattern was intended to provide a homogenous distribution of the disruptive force on the suture among all stitch points. RESULTS: %TWL was 17.53 ± 7.57 in 12 months and 18.5 ± 9% in 18 months indicating durability of the procedure. Patients with a BMI < 35 benefited most from an endoscopic gastroplasty. Leptin did not predict a response to endoscopic gastroplasty and decreased in all patients. In just one case there was a mild bleeding (0.67%) at the insertion point of the helix, which was resolved by sclerotherapy. CONCLUSIONS: Endoscopic gastroplasty offers a real choice for obese patients. This single-center experience with a modified suturing pattern provides a successful technique for weight loss.


Subject(s)
Endoscopy/methods , Gastroplasty/methods , Obesity/surgery , Suture Techniques , Adult , Body Mass Index , Female , Humans , Leptin/blood , Male , Retrospective Studies , Weight Loss
3.
Nefrología (Madr.) ; 34(3): 317-322, mayo-jun. 2014. tab
Article in Spanish | IBECS | ID: ibc-126601

ABSTRACT

El carcinoma tiroideo es una neoplasia que tiene una incidencia más alta en pacientes con enfermedad renal crónica. Durante los últimos años se ha avanzado en las pruebas diagnósticas y terapéuticas. Los pacientes de diálisis son un grupo particular, al ser detectado el cáncer de forma indirecta en el estudio del hiperparatiroidismo secundario y durante el estudio previo al trasplante renal. La tiroidectomía es el tratamiento definitivo, pero en pacientes con riesgo de recidiva es necesaria la terapia ablativa con yodo radioactivo I-131, que es predominantemente excretado por vía renal, por lo que su uso en pacientes en diálisis supone un problema de dosificación. Se presentan dos casos de pacientes en hemodiálisis sometidos a radioablación con yodo radiactivo I-131, que con un manejo multidisplinar produjo los resultados esperados en los pacientes (AU)


Thyroid carcinoma is a neoplasia with a higher incidence in patients with chronic kidney disease. In recent years advances have been made in diagnostic and therapeutic trials. Dialysis patients are a particular group, their cancer being detected indirectly in the study of secondary hyperparathyroidism and during the study prior to renal transplantation. Thyroidectomy is the definitive treatment, but in patients with risk of recurrence, ablative therapy is required using radioactive iodine I-131, which is predominantly eliminated by renal excretion, therefore its use in patients on dialysis poses a problem in terms of dosage. Two cases are presented of patients on haemodialysis undergoing radioablation with radioactive iodine I-131, which with multidisciplinary treatment had the expected results in the patients (AU)


Subject(s)
Humans , Female , Middle Aged , Renal Insufficiency, Chronic/complications , Hyperparathyroidism, Secondary/complications , Thyroid Neoplasms/radiotherapy , Thyroidectomy , Activation Analysis/methods , Iodine Radioisotopes/therapeutic use , 3-Iodobenzylguanidine/therapeutic use
4.
Nefrologia ; 34(3): 317-22, 2014 May 21.
Article in English, Spanish | MEDLINE | ID: mdl-24798564

ABSTRACT

Thyroid carcinoma is a neoplasia with a higher incidence in patients with chronic kidney disease. In recent years advances have been made in diagnostic and therapeutic trials. Dialysis patients are a particular group, their cancer being detected indirectly in the study of secondary hyperparathyroidism and during the study prior to renal transplantation. Thyroidectomy is the definitive treatment, but in patients with risk of recurrence, ablative therapy is required using radioactive iodine I-131, which is predominantly eliminated by renal excretion, therefore its use in patients on dialysis poses a problem in terms of dosage. Two cases are presented of patients on haemodialysis undergoing radioablation with radioactive iodine I-131, which with multidisciplinary treatment had the expected results in the patients.


Subject(s)
Iodine Radioisotopes/therapeutic use , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Renal Dialysis , Thyroid Neoplasms/complications , Thyroid Neoplasms/radiotherapy , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL